US Broker Ratings

Cartesian Therapeutics, Inc. (RNAC): A Biotech Stock with Potential 289.73% Upside

Investors seeking opportunities in the biotechnology sector may want to take a closer look at Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a clinical-stage company specializing in mRNA cell therapies for autoimmune..

Dayforce (DAY) Stock Analysis: Unpacking the 18.81% Potential Upside

As an investor navigating the dynamic landscape of technology stocks, Dayforce, Inc. (DAY) presents an intriguing opportunity, particularly with an 18.81% potential upside based on analyst forecasts. Operating in the..

Grab Holdings Limited (GRAB) Stock Analysis: 19.84% Potential Upside Sparks Investor Interest

Grab Holdings Limited (NASDAQ: GRAB), the Southeast Asian technology titan, is making waves in the investment community with its impressive 19.84% potential upside, according to analysts’ target price ranges. Founded..

Nyxoah SA (NYXH) Stock Analysis: Exploring a Promising 59.92% Potential Upside in the Healthcare Sector

Nyxoah SA (NYSE: NYXH), a Belgium-based innovator in the healthcare sector, is making waves in the medical instruments and supplies industry. As an emerging player specializing in sleep apnea solutions,..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Biotechnology Innovator with a 394.67% Upside Potential

For investors seeking opportunities in the biotechnology sector, aTyr Pharma, Inc. (NASDAQ: ATYR) presents an intriguing proposition. Although still in the clinical stage, the company’s innovative approach to addressing fibrosis..

Viemed Healthcare, Inc. (VMD) Stock Report: Analyst Ratings Signal 92% Upside Potential

Investors seeking opportunities in the healthcare sector may find Viemed Healthcare, Inc. (VMD) an intriguing prospect. With a strong presence in the medical devices industry, this Lafayette, Louisiana-based company specializes..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a Potential 69% Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO), a prominent player in the healthcare sector, is capturing investor interest with its unique position in the drug manufacturing industry. Specializing in specialty and generic..

Absci Corporation (ABSI) Stock Analysis: Exploring a 237.96% Upside Potential with AI-Driven Biotech Innovations

Absci Corporation (NASDAQ: ABSI), a pioneer in leveraging artificial intelligence (AI) for drug creation, is catching the eye of investors with a striking potential upside of 237.96%. This biotech company,..

Yalla Group Limited (YALA) Stock Analysis: Strong ROE and Revenue Growth Signal Potential for Investors

For investors eyeing opportunities in the technology sector, Yalla Group Limited (NYSE: YALA) presents an intriguing case. As a key player in the software application industry, Yalla operates a social..

Vanda Pharmaceuticals (VNDA) Stock Analysis: Unveiling a 193% Potential Upside with Promising Pipeline

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), a biopharmaceutical company based in Washington, D.C., is generating buzz among investors with its robust product pipeline and a substantial potential upside of 193.21%. Operating..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: A Potential 138% Upside in the Medical Device Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a healthcare innovator specializing in medical devices, presents an intriguing opportunity for investors with a potential upside of 138.49%, according to recent analyst ratings. Headquartered..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring a 169.61% Potential Upside in Biotechnology

CytomX Therapeutics, Inc. (CTMX), a prominent player in the biotechnology landscape, commands attention with its innovative approach to oncology treatment and a striking potential upside of 169.61%. This California-based company..

Kaltura, Inc. (KLTR) Stock Analysis: Unveiling a 40% Potential Upside with Strategic SaaS Innovations

Kaltura, Inc. (KLTR), a prominent player in the Software – Application industry, presents a compelling opportunity for investors with its innovative approach to video solutions. Headquartered in New York, this..

Viant Technology Inc. (DSP) Investor Outlook: Exploring a 56.47% Potential Upside

Viant Technology Inc. (NASDAQ: DSP) has been steadily capturing investor attention within the technology sector, specifically in the software application industry. This U.S.-based advertising technology company, with a market cap..

Nerdy Inc. (NRDY) Stock Analysis: Evaluating a Potential 37% Upside in the Online Learning Sector

Nerdy Inc. (NRDY), a technology company entrenched in the software application industry, is making waves with its innovative approach to online learning. Headquartered in Saint Louis, Missouri, Nerdy operates a..

Fulcrum Therapeutics, Inc. (FULC) Investor Outlook: Navigating Volatility with Promising Clinical Prospects

Fulcrum Therapeutics, Inc. (FULC) is a dynamic player in the biotechnology sector, specializing in the development of small molecules aimed at addressing genetically defined diseases. With a market capitalization of..

Compass Therapeutics, Inc. (CMPX) Investor Outlook: A Biotech Gem with Potential 541.86% Upside

For investors with an eye on the biotechnology sector, Compass Therapeutics, Inc. (NASDAQ: CMPX) represents a compelling opportunity. While the broader market has been unpredictable, this clinical-stage biopharmaceutical company is..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Harnessing a 125% Upside Potential

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands out in the healthcare sector with its cutting-edge cell analysis solutions, primarily targeting the medical devices industry. Headquartered in Fremont, California, this company has..

AppLovin Corporation (APP) Stock Analysis: Evaluating the 26.45% Potential Upside for Investors

AppLovin Corporation (NYSE: APP), a key player in the technology sector, is making significant strides on the stock market. With its focus on software applications, the company is renowned for..

Mereo BioPharma Group plc (MREO) Stock Analysis: A Potential 240% Upside in the Biotech Sector

Mereo BioPharma Group plc (NASDAQ: MREO), a promising player in the biotechnology sector, is capturing investor attention with its significant upside potential. Based in London, this biopharmaceutical company is focused..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds